GORE TAG Thoracic Branch Endoprosthesis TAC123115ARecalls & reported problems
W. L. Gore & Associates, Inc. · TAG TBE AORTIC COMPONENT TAG TBE AC 12MMX31MMX15CM · Class 3 · Implant
All models of GORE TAG Thoracic Branch Endoprosthesis (30)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132654178), received between May 2, 2023 and May 2, 2023 — classified as 1 injury.
The most frequently reported specific device problem is “Difficult or Delayed Positioning” (1 report).
1 other recall cover devices cleared under the same FDA submission (P210032); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Difficult or Delayed Positioning1
Patient problems
- Vascular Dissection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMay 2, 2023Difficult or Delayed Positioning; Difficult or Delayed Positioning
ON (B)(6) 2023, THIS PATIENT UNDERWENT EMERGENT ENDOVASCULAR TREATMENT OF A ZONE 2 TYPE B DISSECTION WITH MALPERFUSION, AND WAS IMPLANTED WITH A GORE® TAG® THORACIC BRANCH ENDOPROSTHESIS (TBE) WITH COVERAGE OF THE LEFT SUBCLAVIAN ARTERY (LSA). THREE GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE (VIABAHN DEVICES) WERE IMPLANTED AS BRANCH DEVICES WITHIN THE LSA AS THE APPROPRIATELY SIZED SIDE BRANCH DEVICES WERE NOT AVAILABLE. ADDITIONALLY, IT WAS REPORTED THAT DURING ADVANCEMENT OF THE TBE DEVICE, THE PHYSICIAN ENCOUNTERED ALOT OF DIFFICULTY POSITIONING THE TBE DEVICE TO ALIGN PROPERLY TO THE GREATER CURVE. THE TBE DEVICE HAD BEEN WITHDRAWN BACK DOWN TO THE DESCENDING THORACIC AORTA AT LEAST TEN TIMES IN AN ATTEMPT TO GET THE PORTAL TO LINE UP; AS IT KEPT FLIPPING TO THE LESSER CURVE OF THE AORTA AS OPPOSED TO THE GREATER CURVE. THE DEVICE WAS ALSO COMPLETELY REMOVED FROM THE SHEATH AND REINSERTED IT BACK INTO THE SHEATH IN HOPES OF GETTING IT TO TRACK AND ALIGN BETTER. ADDITIONALLY, IT WAS REPORTED THAT DURING ALL THE EXCESSIVE DEVICE MANIPULATION, THAT THE LUNDERQUIST WIRE PARKED IN THE ASCENDING THORACIC AORTA HAD BEEN DRAGGED BACK TO THE LEVEL OF THE DESCENDING AO
Patient problems: Vascular Dissection
MAUDE report 16856040 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P210032. One submission often covers many models, so check the product and lot details in each record.
- Z-2672-2026 · May 19, 2026 · Open, ClassifiedGORE TAG Thoracic Branch Endoprosthesis Side Branch Component Catalog Numbers (by Region) United States (includes Puerto Rico) and Canada: TSB080806A, TSB081006A, TSB081206A, TSB08
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page